Prosecution Insights
Last updated: April 19, 2026

Troutman Pepper Locke LLP (Icahn Smms)

10 pending office actions • 2 clients

Portfolio Summary

10
Total Pending OAs
2
Final Rejections
8
Non-Final OAs

Client Portfolio (2 clients)

Client (Assignee)Pending OAs
Icahn School Of Medicine AT Mount Sinai 9
Yeda Research And Development Co. Ltd. AT The Weizmann Institute Of Science 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18777129 CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS Yeda Research And Development Co. Ltd. AT The Weizmann Institute Of Science NOAKES, SUZANNE MARIE 1656 Non-Final OA Jul 18, 2024
18755376 COMPOSITIONS AND METHODS FOR TREATING FARBER DISEASE Icahn School Of Medicine AT Mount Sinai MONSHIPOURI, MARYAM 1651 Non-Final OA Jun 26, 2024
18750693 THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM Icahn School Of Medicine AT Mount Sinai HOLLAND, PAUL J 1656 Non-Final OA Jun 21, 2024
18568814 PERFLUOROALKANE SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDIN AND PYRROLO[2,3-D]PYRIMIDIN COMPOUNDS AND USES THEREOF Icahn School Of Medicine AT Mount Sinai CHAO, ALLEN 1622 Non-Final OA Dec 09, 2023
18500881 FUSION PROTEINS COMPRISING DETECTABLE TAGS, NUCLEIC ACID MOLECULES, AND METHOD OF TRACKING A CELL Icahn School Of Medicine AT Mount Sinai D' AMBROSIO, THEA 1654 Non-Final OA Nov 02, 2023
18275287 CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USE Icahn School Of Medicine AT Mount Sinai VAJDA, KRISTIN ANN 1622 Non-Final OA Aug 01, 2023
18034965 METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS Icahn School Of Medicine AT Mount Sinai WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA May 02, 2023
18003088 KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Icahn School Of Medicine AT Mount Sinai SANCHEZ, JUSTIN CHRISTOPHER 1622 Non-Final OA Dec 22, 2022
17612487 METHODS OF CULTURING QUIESCENT HEMATOPOIETIC STEM CELLS AND TREATMENT METHODS Icahn School Of Medicine AT Mount Sinai RIGA, MICHAEL ANGELO 1634 Final Rejection Nov 18, 2021
17041006 METHODS OF TREATING MINIMAL RESIDUAL CANCER Icahn School Of Medicine AT Mount Sinai MCCOLLUM, ANDREA K 1674 Final Rejection Sep 24, 2020

Managing Troutman Pepper Locke LLP (Icahn Smms)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month